Details for New Drug Application (NDA): 217626
✉ Email this page to a colleague
NDA 217626 describes CUPRIC CHLORIDE, which is a drug marketed by Exela Pharma, Rk Pharma, Somerset, and Hospira, and is included in four NDAs. It is available from four suppliers. Additional details are available on the CUPRIC CHLORIDE profile page.
The generic ingredient in CUPRIC CHLORIDE is cupric chloride. Five suppliers are listed for this compound. Additional details are available on the cupric chloride profile page.
The generic ingredient in CUPRIC CHLORIDE is cupric chloride. Five suppliers are listed for this compound. Additional details are available on the cupric chloride profile page.
Summary for 217626
| Tradename: | CUPRIC CHLORIDE |
| Applicant: | Rk Pharma |
| Ingredient: | cupric chloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 217626
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 217626 | ANDA | Northstar Rx LLC | 72603-351 | 72603-351-25 | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-351-25) / 10 mL in 1 VIAL, SINGLE-DOSE (72603-351-01) |
| CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 217626 | ANDA | Archis Pharma LLC | 72819-234 | 72819-234-16 | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (72819-234-16) / 10 mL in 1 VIAL, SINGLE-DOSE (72819-234-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.4MG COPPER/ML | ||||
| Approval Date: | Apr 30, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
